Seriously over-reaction! Net...accounted for payments in wrong period
Making phone calls and I have to tell you nobody likes what DMDN did but they also saying this is overreaction this stock should be down 10-20% not 50%. Company is still running and selling very good strong healthy products. This will get a buyout or go private. They have very strong product line
The problem is that by not putting the $80 million of costs in the correct period, they reported inaccurate earnings. And, with only roughly 22 million shares outstanding, $80 million in costs would have significantly reduced (possibly eliminated) the annual EPS of $2.22 ... so, in summary, it is very possible that DMND lost money while reporting stellar earnings ... we just don't know at this point.